Small Molecules, Big Data: The AI-Powered Future of Oral Obesity Therapies - AktieGo PRISM BioLab and Receptor.AI Partner to Navigate the Undruggable PPI Landscape On March 12, 2026, Tokyo-based PRISM BioLab and U.S.-based TechBio firm Receptor.AI announced a strategic collaboration t...

Small Molecules, Big Data 🔥
PRISM BioLab + Receptor.AI team up: AI-powered oral pills replacing GLP-1 injections for obesity.
PepMetics® × physics AI = stable drugs hitting undruggable targets.
2026 market shift is here 👇
Full analysis:
aktiego.com/sectors/biot...
#Biotech #AI #Obesity #TechBio

Recursion announced yesterday that the company will participate in a number of upcoming investor conferences.
👉 Check out the webcasts at ir.recursion.com.
#investor #financial #AI #drugdiscovery #TechBio

It's been a minute but I found my way back to a conference; I'll be at AGBT this week representing @stellaromics.bsky.social to lend my experience communicating all things #spatialbio #bioinformatics #techbio #ai ! Looking forward to meeting new folks, please reach out if interested! 🧬🔬

Recursion CSO Dave Hallett was recently appointed as an AI Champion by the UK government. He’s one of 8 AI Champions and will be representing the life sciences industry, helping to inform, guide, and accelerate AI adoption plans in that space.
👉 Learn more: delivery.ai.gov.uk/48/ #TechBio #AI #UK

Show and Tell 2026 · Luma Philadelphia is going to build and tell people about this February 21st, 2026 Join Bits in Bio Philadelphia and Code and Coffee Philadelphia as we focus on a…

You want to build in #Techbio #Lifescience and leverage AI Agents, come to Show and Tell 2026 in Philadelphia where Bits in Bio and Code and Coffee Philadelphia team up creating interdisciplinary teams from life science and tech to collaborate and build for the day:

luma.com/jzwdvqdr

TechBio Talks Panel with Katie Couric, Renee Gala, Reid Hoffman, Eric Topol, and Eric Lefkofsky YouTube video by Recursion

#BioTech - #Recursion Panel
Very interesting

#TechBio Talks Panel with Katie Couric, Renee Gala, Reid Hoffman, Eric Topol, and Eric Lefkofsky

youtu.be/KEhX0UNjI0o?...

Reflections from JPM: a turning point for platform companies like Lunai Bioworks

From JPM 2026, one takeaway is clear: urgency in biopharma partnering is rising fast, and our BioSymetrics team felt it across conversations and meetings. #TechBio #JPM2026 #DrugDiscovery

Investing in Controllable Biology and Techbio Workflows | Biotech Venture Deals This Week | VentureRadar Investing in Controllable Biology and Techbio Workflows | Biotech Venture Deals This Week

Weekly biotech roundup 🔬 Controllable biology and techbio workflows lead: engineered proteins, next-gen antibodies, non-viral delivery, and AI for discovery, yield, and trials. We round up the investments you should know about → www.ventureradar.com/articles/Inv...

#Biotech #Techbio

Bits in Bio Philadelphia and Code & Coffee Philadelphia presents Show and Tell 2026. Please join us on Feb. 21st
Enrollment is live:
luma.com/jzwdvqdr

#Biotech #Techbio #AIXBIO #Bioinformatics #Medtech #Healthtech

"clinical validation isnt real," i assure myself as i close my eyes and ram the JPM auditorium with a commandeered waymo. #JPM #JPM2026 #TECHBIO #BIOTECH

Telling investors we are "closing the loop" between patients and medicine as I tie two ethernet cables together. they give me a standing ovation as I transition into the world's first liminal executive. #techbio #JPM #JPM26 #JPM2026

Leveraging AI & real-world patient data to accelerate drug discovery. In a recent webinar, Sid Jain and Hayley Donnella of Recursion spoke to Shane Woods at Tempus AI about how patient data is driving the latest advances in AI drug discovery. www.tempus.com/resources/co... #TechBio #data 🧪

AI-native drugs are hitting 80-90% Phase I success rates. From Pfizer's 30-day discovery cycle to the rise of Agentic AI, see how #AI is transforming #DrugDiscovery.

drive.google.com/file/d/1a6et...

#TechBio #BioPharma #JPM26 #JPM

AI-native drugs are hitting 80-90% Phase I success rates. From Pfizer's 30-day discovery cycle to the rise of Agentic AI, see how #AI is transforming #DrugDiscovery.

drive.google.com/file/d/1a6et...

#TechBio #BioPharma #JPM26 #JPM

#o2hGroup #JPMWeek2026 #JPM #RESIJPM #LifeSciences #Biotech #Techbio #Innovation #Collaboration

2025 marked a turning point for #TechBio, where technology meets biology, when concepts finally began to take shape in the real world.
𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐓𝐞𝐜𝐡𝐁𝐢𝐨 𝐢𝐧 𝐚𝐜𝐭𝐢𝐨𝐧?
👉Discover the technologies that matter on our blog lnkd.in/ePQy4kin
👇Watch and listen to our experts right now youtu.be/d69VSutDeVQ 👇

Scripta Therapeutics raises $12 million seed funding The Oxford-based tech bio firm intends to use the funds raised to focus on delaying the disease progression of Alzheimer’s disease and other neurodegenerative conditions.

Oxford-based tech bio firm Scripta Therapeutics intends to use the funds raised to focus on delaying the disease progression of Alzheimer’s disease and other neurodegenerative conditions.

healthcaretoday.com/article/scri...

#healthcare #innovation #techbio #Alzheimers #neurodegeneration

Mapping Microglia To Unlock New Paths in Neuroscience Dr. Najat Khan of Recursion shared insights into the creation of the Microglia Map and what it could mean for future drug discovery.

In a new story in Technology Networks, incoming CEO and President Najat Khan shared insights into the creation of the Microglia Map in partnership with Roche and Genentech and what it could mean for future drug discovery. #neuroscience #microglia #TechBio www.technologynetworks.com/drug-discove...

One Thing I Wish My Family Understood About My Work at Recursion YouTube video by Recursion

In a new video, Communications and Culture Fellow Katherine Matsumoto asks Recursionauts: “What is one thing you wish your families understood about the work that you do?” For many, it’s all about the patients.
#onething #Recursionaut #culture #TechBio #drugdiscovery

www.youtube.com/shorts/ougrI...

Presenting REC-102: Preclinical in vivo updates for a potential ENPP1 inhibitor for the treatment of hypophosphatasia (HPP). Results of the study have been published in the Journal of Bone and Mineral Research.
👉 Read the paper: academic.oup.com/jbmr/advance... #HPP #ENPP1 #TechBio

MIT Club of Boston

🗓️ Nov 13 | 📍 Koch Biology Building
🔗 Register: mitbiosummit.com
Hosted in partnership with the MIT Department of Biology

🗓️ Nov 13 | ⏱️1:30 PM - 5:00 PM 📍 Koch Biology Building
#MITBioSummit #AIinHealthcare #TechBio #MITBiology

🗓️ Nov 13 | ⏱️3:45 PM - 4:45 📍 Koch Biology Building
🔗 Register: mitbiosummit.com
#MITBioSummit #AIinHealthcare #DigitalHealth #TechBio

Bits in Bio Philadelphia November Happy Hour · Luma Bits in Bio is a global community of leaders and experts at the intersection of software and biotech. Our mission is to bring together the tech and bio…

Bits in Bio Philadelphia Happy hour tomorrow: luma.com/y31idgl1

Come on out #biotech #informatics #aixbio #techbio

AI in Drug Development–TechBio Reality Check
Moderator: Tarun Walia, Novo Nordisk
Panel: Sandeep Burugupalli at AstraZeneca & MIT Professors Francisco Sanchez-Rivera & Sergey Ovchinnikov
🗓️ Nov 13 | ⏱️2:15 PM - 3:15 📍 Koch Bio Bldg
#MITBioSummit #AIinHealthcare #DrugDiscovery #TechBio #MITBiology

The Making of the World's First Microglia Map to Explore New Targets for Neurological Diseases YouTube video by Recursion

In our latest Explain the Impact video, we share the inside story of the world's first Microglia Map from Recursion and Roche and Genentech to help unlock new targets in neurodegenerative diseases. #neuroscience #techbio youtube.com/shorts/xvPIQ...

AI is Powerful and Universal.
Keynote Speaker: Prof. Dimitris Bertsimas, Vice Provost for Open Learning, MIT
🗓️ Nov 13 | 📍 Koch Biology Building
Keynote Topic: Holistic AI for medicine & the future of AI education
🔗 Register: mitbiosummit.com
#MITBioSummit #AIinHealthcare #TechBio

How a First-of-its-Kind “Microglia Map” from Recursion and Roche and Genentech Could Unlock New Treatments for Neurodegenerative Diseases A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a wide range of neurological dise...

💥 Recursion has achieved a $30 million milestone payment from its partners, Roche and Genentech, following the acceptance of the Microglia Map – a first-of-its-kind whole genome map of the brain’s immune cells.

👉Learn more: www.recursion.com/news/how-a-f... #neuroscience #TechBio

Bits in Bio Philadelphia November Happy Hour · Luma Bits in Bio is a global community of leaders and experts at the intersection of software and biotech. Our mission is to bring together the tech and bio…

Hello everyone, Bits in Bio Philly is having another Happy Hour November 7th at 5 PM:

luma.com/y31idgl1

#biotech #techbio #AIXBIO #informatics #bioinfomratics #medtech #informatics #Philadelphia

Featuring leaders from MIT, AstraZeneca, Novo Nordisk, Hartford HealthCare & Harvard T.H. Chan School of Public Health.

🗓️ Nov 13 | 📍 Koch Biology Building

#MITBioSummit #AIinHealthcare #TechBio

Speakers from MIT, AstraZeneca, Novo Nordisk, Hartford HealthCare & Harvard T.H. Chan School of Public Health.

#MITBioSummit #AIinHealthcare #TechBio #BostonInnovation